Physician profile
Joe Lee
NPI 1437313095
$485,796.00
in general payments reported to CMS, 2019-2025
22 companies · $27K in 2025
The $27K reported for 2025 was more than what 81% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74K · 2020: $63K · 2021: $80K · 2022: $104K · 2023: $97K · 2024: $41K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $107K · Travel and Lodging: $30K · Consulting Fee: $26K · Food and Beverage: $2,869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $106,622.45 |
| Travel and Lodging | $29,507.02 |
| Consulting Fee | $26,481.62 |
| Food and Beverage | $2,868.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart Sa | $194,177.47 | 2019-2025 | Perla Tl - Cortical Screw, Juliet Ll - Hyperlordotic Lateral Cage Ti-Life |
| Choice Spine, LLC | $175,075.42 | 2019-2025 | Tigershark C, Boomerang, Veo Lateral Interbody Fusion System |
| Spineart USA INC | $102,969.29 | 2019-2025 | Perla C, Juliet Ll |
| Integrity Implants INC. | $6,922.39 | 2021-2022 | |
| Kyocera Medical Technologies, INC. | $5,000.00 | 2019 | |
| Boston Scientific Corporation | $450.84 | 2022-2024 | Apollo Esg System, Bodyguardian |
| Medtronic, INC. | $341.29 | 2024 | Kyphon Express II Kyphopak Tray, Cobalt Dr Mri Surescan |
| Nuvasive, INC. | $151.02 | 2019 | |
| Gilead Sciences, INC. | $124.78 | 2023 | Vemlidy |
| Smith+Nephew, INC. | $124.20 | 2020-2025 | Pico 14 |
| Cerapedics INC. | $97.49 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Baxter Healthcare | $53.13 | 2023-2025 | Floseal |
| Integrity Implants INC. Dba Accelus | $49.84 | 2023-2024 | |
| Si-Bone, INC. | $45.92 | 2021-2022 | |
| Clariance, INC. | $45.25 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $42.08 | 2021 | |
| Davol INC. | $38.21 | 2025 | Arista |
| Centinel Spine, LLC | $26.82 | 2025 | Prodisc C Vivo |
| Amarin Pharma, INC. | $24.50 | 2021 | |
| Medtronic USA, INC. | $24.08 | 2020 | |
| Providence Medical Technology, INC. | $11.98 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$78,198.69 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.